Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Kangaroo Group's base in Parliament challenged

Corporate Europe Observatory has written to the European Parliament's College of Quaestors (the body responsible for administrative matters regarding the running of the Parliament) to question why the Kangaroo Group has an office in the Parliament building. The Kangaroo Group is not a registered Intergroup, nor does it appear to have any other official status vis-a-vis the European Parliament. But members of the group, which include some 50 big companies, including Goldman Sachs, BP and Volkswagen, benefit from the privileged access to the Parliament and to MEPs.

The arms industry uses the Kangaroo Group as one of its lobbying channels to shape EU security and defence policies, via the Kangaroo Group's working group on “Space, Defence & Security”, as CEO has highlighted in its new report on the arms lobby. CEO argues that such activities should not be coordinated from an office inside the European Parliament, and urges the Quaestors to ask the Kangaroo Group to find office space elsewhere.

 

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

The corporate lobby tour

Policy-makers want their decisions to be based on the best available evidence; controlling the relevant science is therefore a key component of the strategy of the lobbyists who can afford it. During two days, this conference will analyse evidence politics and discuss evidence policies to find out how to make the existing EU scientific evidence appraisal system evolve towards better serving the public interest.
The European Ombudsman has opened a case on the European Commission's industry-dominated Expert Group on the risky and dangerous practice of 'fracking for natural gas.
Policy prescriptions: the firepower of the EU pharmaceutical lobby and implications for public health
A citizen's tour of corporate power in Brussels 03/09/15

Stop the Crop

Alternative Trade Mandate